美国NDC复合药物数据库文件

药品名称：商品名称：药品NDC：报告期内： -格式:2020-5-3
NDC包装id：市场分类：活性成分：持证企业：

美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)

药品名称(分析)

商品名

药品NDC

专利人(分析)

报告期内

活性成分

市场分类

规格(分析)

NDC包装id

Pyridoxine HCl

HUMAN COMPOUNDED DRUG

26436-5002

Hybrid Pharma

2024-2

PYRIDOXINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

100 mg/1 mL

26436-5002-1

Atropine Sulfate Monohydrate 0.05%

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.5 mg/1 mL

83826-9012-3

Prednisolone Phosphate 1%, Moxifloxacin HCl 0.5%, Ketorolac Tromethamine 0.5%

HUMAN COMPOUNDED DRUG

83826-9017

OSRX, Inc.

2024-2

MOXIFLOXACIN HYDROCHLORIDE; KETOROLAC TROMETHAMINE; PREDNISOLONE SODIUM PHOSPHATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

5 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL

83826-9017-8

Bimatoprost 0.01%, Brimonidine Tartrate 0.1%, Dorzolamide 2%

HUMAN COMPOUNDED DRUG

83826-9030

OSRX, Inc.

2024-2

DORZOLAMIDE HYDROCHLORIDE; BRIMONIDINE TARTRATE; BIMATOPROST

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

20 mg/1 mL; 1 mg/1 mL; .1 mg/1 mL

83826-9030-5

Brimonidine Tartrate 0.1%, Dorzolamide 2%

HUMAN COMPOUNDED DRUG

83826-9066

OSRX, Inc.

2024-2

DORZOLAMIDE HYDROCHLORIDE; BRIMONIDINE TARTRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

20 mg/1 mL; 1 mg/1 mL

83826-9066-5

Tropicamide 1%, Phenylephrine HCl 2.5%

HUMAN COMPOUNDED DRUG

83826-9065

OSRX, Inc.

2024-2

PHENYLEPHRINE HYDROCHLORIDE; TROPICAMIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

25 mg/1 mL; 10 mg/1 mL

83826-9065-0

Timolol 0.5, Dorzolamide 2, Bimatoprost 0.01

HUMAN COMPOUNDED DRUG

83826-9032

OSRX, Inc.

2024-2

BIMATOPROST; TIMOLOL MALEATE; DORZOLAMIDE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.1 mg/1 mL; 5 mg/1 mL; 20 mg/1 mL

83826-9032-5

Morphine Sulfate

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

73013-1036-1

Morphine Sulfate

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

73013-1010-1

Fentanyl Citrate

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 ug/1 mL

73013-1016-1

Hydromorphone HCl

HUMAN COMPOUNDED DRUG

73013-1044

OurPharma LLC

2024-2

HYDROMORPHONE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

73013-1044-1

Hydromorphone HCl

HUMAN COMPOUNDED DRUG

73013-1030

OurPharma LLC

2024-2

HYDROMORPHONE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.2 mg/1 mL

73013-1030-1

Morphine Sulfate

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

73013-1022-1

Hydromorphone HCl

HUMAN COMPOUNDED DRUG

73013-1042

OurPharma LLC

2024-2

HYDROMORPHONE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

73013-1042-1

Hydromorphone HCl

HUMAN COMPOUNDED DRUG

73013-1045

OurPharma LLC

2024-2

HYDROMORPHONE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

73013-1045-1

Hydromorphone HCl

HUMAN COMPOUNDED DRUG

73013-1040

OurPharma LLC

2024-2

HYDROMORPHONE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

73013-1040-1

Tropicamide 1%, Cyclopentolate 1%, Phenylephrine 2.5%, Ketorolac 0.5%

HUMAN COMPOUNDED DRUG

71266-8240

Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories

2024-2

PHENYLEPHRINE HYDROCHLORIDE; KETOROLAC TROMETHAMINE; TROPICAMIDE; CYCLOPENTOLATE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

25 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL

71266-8240-1

Tropicamide 1%, Cyclopentolate 1%, Phenylephrine 2.5%, Ketorolac 0.5%

HUMAN COMPOUNDED DRUG

71266-8240

Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories

2024-2

PHENYLEPHRINE HYDROCHLORIDE; KETOROLAC TROMETHAMINE; TROPICAMIDE; CYCLOPENTOLATE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

25 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL

71266-8240-5

Moxifloxacin HCl

HUMAN COMPOUNDED DRUG

71266-8613

Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories

2024-2

MOXIFLOXACIN HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

71266-8613-1

Povidone Iodine

HUMAN COMPOUNDED DRUG

71266-6535

Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories

2024-2

POVIDONE-IODINE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

50 mg/1 mL

71266-6535-3

网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

医药代理商群２：

医药代理商群３：